adefovir dipivoxil has been researched along with 9-(2-(phosphonomethoxy)ethyl)adenine diphosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erion, MD; Hong, Z; Lin, CC; Vitarella, D; Yeh, LT | 1 |
| Česnek, M; Dvoráková, A; Janeba, Z; Mertlíková-Kaiserová, H; Šmídková, M; Tloust'ová, E | 1 |
2 other study(ies) available for adefovir dipivoxil and 9-(2-(phosphonomethoxy)ethyl)adenine diphosphate
| Article | Year |
|---|---|
Remofovir mesylate: a prodrug of PMEA with improved liver-targeting and safety in rats and monkeys.
Topics: Adenine; Animals; Antiviral Agents; Autoradiography; Carbon Radioisotopes; Dose-Response Relationship, Drug; Drug Delivery Systems; Haplorhini; Hepatitis B, Chronic; Kidney; Liver; Mesylates; Organophosphonates; Organophosphorus Compounds; Prodrugs; Rats; Species Specificity; Tissue Distribution | 2004 |
Amidate prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine as inhibitors of adenylate cyclase toxin from Bordetella pertussis.
Topics: Adenine; Adenylate Cyclase Toxin; Animals; Anti-Bacterial Agents; Bordetella pertussis; Caco-2 Cells; Cell Line, Tumor; Cell Survival; Humans; Inhibitory Concentration 50; Macrophages; Mice; Microbial Sensitivity Tests; Organophosphonates; Prodrugs | 2014 |